Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin
- 12 March 1994
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 343 (8898) , 667-668
- https://doi.org/10.1016/s0140-6736(94)92659-x
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Persistent B19 Parvovirus Infection in Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-1): A Treatable Cause of Anemia in AIDSAnnals of Internal Medicine, 1990
- Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin TherapyNew England Journal of Medicine, 1989
- PROLONGED PARVOVIRUS B19 INFECTION WITH SEVERE ANAEMIA IN A BONE MARROW TRANSPLANT RECIPIENTBritish Journal of Haematology, 1989
- Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV)Epidemiology and Infection, 1983